SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-117139
Filing Date
2019-04-24
Accepted
2019-04-24 16:15:56
Documents
5
Period of Report
2019-06-04
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d689457ddef14a.htm DEF 14A 349575
2 GRAPHIC g689457g07s51.gif GRAPHIC 4119
3 GRAPHIC g689457g51t18.gif GRAPHIC 2991
4 GRAPHIC g689457g78m61.gif GRAPHIC 2219
5 GRAPHIC g689457g79l25.gif GRAPHIC 2512
  Complete submission text file 0001193125-19-117139.txt   367545
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 19764016
SIC: 2834 Pharmaceutical Preparations